These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 31623387)

  • 1. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
    Kasprzak A; Adamek A
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms.
    Unger C; Kramer N; Unterleuthner D; Scherzer M; Burian A; Rudisch A; Stadler M; Schlederer M; Lenhardt D; Riedl A; Walter S; Wernitznig A; Kenner L; Hengstschläger M; Schüler J; Sommergruber W; Dolznig H
    Oncogene; 2017 Sep; 36(38):5341-5355. PubMed ID: 28534511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive ceRNA network analysis and experimental studies identify an IGF2-AS/miR-150/IGF2 regulatory axis in colorectal cancer.
    Liu B; Liu Y; Zhou M; Yao S; Bian Z; Liu D; Fei B; Yin Y; Huang Z
    Pathol Res Pract; 2020 Oct; 216(10):153104. PubMed ID: 32853944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications.
    Belharazem D; Magdeburg J; Berton AK; Beissbarth L; Sauer C; Sticht C; Marx A; Hofheinz R; Post S; Kienle P; Ströbel P
    J Gastroenterol; 2016 Oct; 51(10):971-84. PubMed ID: 26984550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for colorectal cancer by adenovirus-mediated siRNA targeting CD147 based on loss of the IGF2 imprinting system.
    Pan Y; He B; Chen J; Sun H; Deng Q; Wang F; Ying H; Liu X; Lin K; Peng H; Xie H; Wang S
    Int J Oncol; 2015 Nov; 47(5):1881-9. PubMed ID: 26397886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene.
    Cruz-Correa M; Zhao R; Oviedo M; Bernabe RD; Lacourt M; Cardona A; Lopez-Enriquez R; Wexner S; Cuffari C; Hylind L; Platz E; Cui H; Feinberg AP; Giardiello FM
    Epigenetics; 2009 Feb; 4(2):114-8. PubMed ID: 19242102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways.
    Zhang J; Chen B; Li H; Wang Y; Liu X; Wong KY; Chan WN; Chan AK; Cheung AH; Leung KT; Dong Y; Pan Y; Ke H; Liang L; Zhou Z; Xiao J; Wong CC; Wu WK; Cheng AS; Ma BB; Yu J; Lo KW; Kang W;
    J Pathol; 2023 Feb; 259(2):205-219. PubMed ID: 36373776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF2 loss of imprinting enhances colorectal cancer stem cells pluripotency by promoting tumor autophagy.
    Gao T; Liu X; He B; Pan Y; Wang S
    Aging (Albany NY); 2020 Nov; 12(21):21236-21252. PubMed ID: 33173015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive methylation analysis of imprinting-associated differentially methylated regions in colorectal cancer.
    Hidaka H; Higashimoto K; Aoki S; Mishima H; Hayashida C; Maeda T; Koga Y; Yatsuki H; Joh K; Noshiro H; Iwakiri R; Kawaguchi A; Yoshiura KI; Fujimoto K; Soejima H
    Clin Epigenetics; 2018 Dec; 10(1):150. PubMed ID: 30509319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism.
    Ellis BC; Graham LD; Molloy PL
    Biochim Biophys Acta; 2014 Feb; 1843(2):372-86. PubMed ID: 24184209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer].
    Zhang FR; He XB; Yang YH; Xie W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):31-4. PubMed ID: 12579496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF2-derived miR-483 mediated oncofunction by suppressing DLC-1 and associated with colorectal cancer.
    Cui H; Liu Y; Jiang J; Liu Y; Yang Z; Wu S; Cao W; Cui IH; Yu C
    Oncotarget; 2016 Jul; 7(30):48456-48466. PubMed ID: 27366946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer.
    Cheng YW; Idrees K; Shattock R; Khan SA; Zeng Z; Brennan CW; Paty P; Barany F
    Int J Cancer; 2010 Aug; 127(3):568-77. PubMed ID: 19957330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4.
    Schagdarsurengin U; Lammert A; Schunk N; Sheridan D; Gattenloehner S; Steger K; Wagenlehner F; Dansranjavin T
    Cell Commun Signal; 2017 Oct; 15(1):40. PubMed ID: 29017567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA 91H regulates IGF2 expression by interacting with IGF2BP2 and promotes tumorigenesis in colorectal cancer.
    Gao T; Liu X; He B; Pan Y; Wang S
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):664-671. PubMed ID: 32070145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
    Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Morita M; Nakao M; Baba H
    Ann Surg Oncol; 2014 Apr; 21(4):1166-74. PubMed ID: 24318096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.
    Zhao X; Liu X; Wang G; Wen X; Zhang X; Hoffman AR; Li W; Hu JF; Cui J
    Oncotarget; 2016 Aug; 7(32):51349-51364. PubMed ID: 27275535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer.
    Cui H
    Dis Markers; 2007; 23(1-2):105-12. PubMed ID: 17325430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced sensitivity to IGF-II signaling links loss of imprinting of IGF2 to increased cell proliferation and tumor risk.
    Kaneda A; Wang CJ; Cheong R; Timp W; Onyango P; Wen B; Iacobuzio-Donahue CA; Ohlsson R; Andraos R; Pearson MA; Sharov AA; Longo DL; Ko MS; Levchenko A; Feinberg AP
    Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20926-31. PubMed ID: 18087038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.